Brief: Ashington Innovation Says Proposed Reverse Takeover Of Cell Therapy Terminated

Ashington Innovation

24/01/2024 07:40

Jan 24 (Reuters) - Ashington Innovation PLC  ASHI.L :
    * ASHINGTON INNOVATION  - TERMINATION OF PROPOSED REVERSE
TAKEOVER
    * ASHINGTON INNOVATION PLC - CONCLUDED THAT IT WAS NO LONGER
IN
BEST INTERESTS OF SHAREHOLDERS TO PROCEED
    * ASHINGTON INNOVATION PLC - GIVEN CURRENT MARKET CONDITIONS
IT
WAS NOT CERTAIN THAT REQUIRED FUNDING FOR TRANSACTION WOULD BE
AVAILABLE
    * ASHINGTON - PROPOSED ACQUISITION OF CALON
CARDIO-TECHNOLOGY, WAS
CONDITIONAL ON TAKEOVER OF CELL THERAPY, THIS ACQUISITION WILL
ALSO NOT PROCEED
    * ASHINGTON INNOVATION PLC - WILL CONTINUE TO EVALUATE OTHER
ACQUISITION OPPORTUNITIES IN TECHNOLOGY SECTOR

Source text for Eikon:  ID:nRSX6796Aa 
Further company coverage:  ASHI.L 

 ((Reuters.Briefs@thomsonreuters.com;))